Largest pharmaceutical companies by total assets
Everything the company owns, as its balance sheet stood at the end of the latest fiscal year.
Pfizer leads the 61 pharmaceutical companies ranked by total assets, at TRY 10.5T, ahead of Johnson & Johnson (TRY 10.05T) and Sanofi (TRY 7.1T). Figures as of 18 Nov 2026, 18:41 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- First
- PfizerTRY 10.5T
- Median
- TRY 177.7B
- Combined market value
- TRY 256.86T
- Countries
- 10
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | Total assets ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | PfizerPFE · Health Care | TRY 10.5T | TRY 8.11T | TRY 1,422.05 | 0.97% down | 14% up | ||
| 2 | Johnson & JohnsonJNJ · Health Care | TRY 10.05T | TRY 33.44T | TRY 13,892.14 | 1.17% down | 38% up | ||
| 3 | SanofiSNY · Health Care | TRY 7.1T | TRY 5.73T | TRY 2,387.65 | 0.40% down | 4% down | ||
| 4 | Merck & CoMRK · Health Care | TRY 6.9T | TRY 17.22T | TRY 6,985.00 | 3.40% down | 51% up | ||
| 5 | AbbVieABBV · Health Care | TRY 6.76T | TRY 25.64T | TRY 14,505.46 | 1.78% down | 26% up | ||
| 6 | AstraZenecaAZN · Health Care | TRY 5.75T | TRY 14.06T | TRY 9,063.89 | 1.40% down | 2% up | ||
| 7 | Eli LillyLLY · Health Care | TRY 5.67T | TRY 62.71T | TRY 70,399.86 | 1.39% down | 35% up | ||
| 8 | NovartisNVS · Health Care | TRY 5.6T | TRY 14.86T | TRY 7,870.06 | 1.94% down | 25% up | ||
| 9 | Takeda PharmaceuticalTAK · Health Care | TRY 4.9T | TRY 3.45T | TRY 1,079.08 | 1.13% down | 54% up | ||
| 10 | Bristol-Myers SquibbBMY · Health Care | TRY 4.54T | TRY 6.21T | TRY 3,036.76 | 1.86% down | 34% up | ||
| 11 | Abbott LaboratoriesABT · Health Care | TRY 4.37T | TRY 9.13T | TRY 5,271.09 | 0.19% down | 17% down | ||
| 12 | GSKGSK · Health Care | TRY 4.09T | TRY 4.94T | TRY 2,462.29 | 0.85% down | 6% up | ||
| 13 | Novo NordiskNVO · Health Care | TRY 4.06T | TRY 8.81T | TRY 1,999.54 | 2.59% down | 17% down | ||
| 14 | Teva Pharmaceutical IndustriesTEVA · Health Care | TRY 2.06T | TRY 2.48T | TRY 2,126.64 | 1.07% down | 74% up | ||
| 15 | Regeneron PharmaceuticalsREGN · Health Care | TRY 2.05T | TRY 4.95T | TRY 47,819.57 | 1.01% down | 36% up | ||
| 16 | ViatrisVTRS · Health Care | TRY 1.88T | TRY 1.19T | TRY 1,042.26 | 1.05% up | 96% up | ||
| 17 | Vertex PharmaceuticalsVRTX · Health Care | TRY 1.29T | TRY 6.89T | TRY 27,185.87 | 0.90% up | 27% up | ||
| 18 | GrifolsGRFS · Health Care | TRY 1.1T | TRY 290.6B | TRY 426.94 | 1.91% down | 1% up | ||
| 19 | Royalty PharmaRPRX · Health Care | TRY 989.6B | TRY 2.01T | TRY 3,501.28 | 1.08% up | 78% up | ||
| 20 | ZoetisZTS · Health Care | TRY 780.1B | TRY 1.74T | TRY 4,294.39 | 1.99% up | 29% down | ||
| 21 | Elanco Animal HealthELAN · Health Care | TRY 673.7B | TRY 679.4B | TRY 1,359.26 | 4.26% up | 20% up | ||
| 22 | GenmabGMAB · Health Care | TRY 649.3B | TRY 1.6T | TRY 2,598.22 | 0.86% down | 70% up | ||
| 23 | Jazz PharmaceuticalsJAZZ · Health Care | TRY 588.1B | TRY 799.9B | TRY 12,462.01 | 2.65% up | 37% up | ||
| 24 | BeOne MedicinesONC · Health Care | TRY 413B | TRY 2.33T | TRY 20,440.28 | 1.93% down | 17% up | ||
| 25 | United TherapeuticsUTHR · Health Care | TRY 397.4B | TRY 1.25T | TRY 29,400.77 | 0.20% down | 23% up | ||
| 26 | BioMarin PharmaceuticalBMRN · Health Care | TRY 383B | TRY 591.8B | TRY 3,055.17 | 3.53% up | 11% up | ||
| 27 | Dr. Reddy's LaboratoriesRDY · Health Care | TRY 310.9B | TRY 632.8B | TRY 759.00 | 1.75% up | 5% up | ||
| 28 | Roivant SciencesROIV · Health Care | TRY 287.9B | TRY 1.41T | TRY 1,944.82 | 0.39% down | 90% up | ||
| 29 | Alnylam PharmaceuticalsALNY · Health Care | TRY 250.5B | TRY 1.02T | TRY 7,614.61 | 3.53% down | 66% down | ||
| 30 | Amneal PharmaceuticalsAMRX · Health Care | TRY 185.5B | TRY 388.3B | TRY 1,114.39 | 4.62% up | 83% up | ||
| 31 | Ionis PharmaceuticalsIONS · Health Care | TRY 177.7B | TRY 234B | TRY 1,404.90 | 3.32% up | 64% down | ||
| 32 | PTC TherapeuticsPTCT · Health Care | TRY 146.2B | TRY 254.4B | TRY 3,045.34 | 0.03% up | 20% down | ||
| 33 | AlkermesALKS · Health Care | TRY 125.4B | TRY 398.2B | TRY 2,369.49 | 3.37% up | 58% up | ||
| 34 | InsmedINSM · Health Care | TRY 114.2B | TRY 1.34T | TRY 6,087.14 | 0.96% down | 40% down | ||
| 35 | Legend BiotechLEGN · Health Care | TRY 87.4B | TRY 158.9B | TRY 819.08 | 0.81% up | 42% down | ||
| 36 | Ligand PharmaceuticalsLGND · Health Care | TRY 78.7B | TRY 303.5B | TRY 15,172.47 | 2.39% up | 43% up | ||
| 37 | Ascendis PharmaASND · Health Care | TRY 72.9B | TRY 899.4B | TRY 13,712.09 | 0.25% up | 28% up | ||
| 38 | CytokineticsCYTK · Health Care | TRY 71.8B | TRY 362.9B | TRY 2,605.28 | 0.01% up | 20% down | ||
| 39 | Arrowhead PharmaceuticalsARWR · Health Care | TRY 69.9B | TRY 310B | TRY 2,192.97 | 1.14% up | 10% up | ||
| 40 | Madrigal PharmaceuticalsMDGL · Health Care | TRY 63.5B | TRY 478.2B | TRY 20,584.27 | 3.29% down | 24% down | ||
| 41 | TG TherapeuticsTGTX · Health Care | TRY 53.6B | TRY 503.8B | TRY 3,333.08 | 5.38% up | 107% up | ||
| 42 | Praxis Precision MedicinesPRAX · Health Care | TRY 47.3B | TRY 435.4B | TRY 15,577.22 | 1.24% up | 61% up | ||
| 43 | Cogent BiosciencesCOGT · Health Care | TRY 47.3B | TRY 247.6B | TRY 1,422.81 | 1.29% up | 20% down | ||
| 44 | BridgeBio PharmaBBIO · Health Care | TRY 47.2B | TRY 768B | TRY 3,942.60 | 1.78% up | 17% up | ||
| 45 | Mirum PharmaceuticalsMIRM · Health Care | TRY 42.5B | TRY 304.3B | TRY 4,661.57 | 0.52% up | 31% up | ||
| 46 | Corcept TherapeuticsCORT · Health Care | TRY 42.2B | TRY 377B | TRY 3,444.29 | 2.54% down | 8% down | ||
| 47 | Belite BioBLTE · Health Care | TRY 39.4B | TRY 322.9B | TRY 7,950.26 | 0.06% down | 31% up | ||
| 48 | Spyre TherapeuticsSYRE · Health Care | TRY 39.2B | TRY 464.2B | TRY 4,887.77 | 3.30% up | 286% up | ||
| 49 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | TRY 38.5B | TRY 377.8B | TRY 4,808.08 | 0.23% up | 126% up | ||
| 50 | Summit TherapeuticsSMMT · Health Care | TRY 37.9B | TRY 425B | TRY 531.35 | 1.27% down | 36% down | ||
| 51 | Axsome TherapeuticsAXSM · Health Care | TRY 34.8B | TRY 357.2B | TRY 6,790.73 | 0.96% down | 7% down | ||
| 52 | Protagonist TherapeuticsPTGX · Health Care | TRY 33.7B | TRY 415B | TRY 6,357.99 | 1.11% up | 46% up | ||
| 53 | ABIVAXABVX · Health Care | TRY 32.7B | TRY 370.9B | TRY 4,236.64 | 2.31% up | 27% down | ||
| 54 | Travere TherapeuticsTVTX · Health Care | TRY 30.5B | TRY 247.9B | TRY 2,582.33 | 0.20% up | 44% up | ||
| 55 | Edgewise TherapeuticsEWTX · Health Care | TRY 27.9B | TRY 230.8B | TRY 2,107.72 | 0.59% down | 88% up | ||
| 56 | Dianthus TherapeuticsDNTH · Health Care | TRY 26.8B | TRY 248.3B | TRY 4,409.13 | 0.51% up | 113% up | ||
| 57 | Oruka TherapeuticsORKA · Health Care | TRY 24.6B | TRY 329.1B | TRY 4,852.47 | 0.11% down | 241% up | ||
| 58 | Rhythm PharmaceuticalsRYTM · Health Care | TRY 24.2B | TRY 419.8B | TRY 6,055.37 | 2.96% up | 13% up | ||
| 59 | Definium TherapeuticsDFTX · Health Care | TRY 22.2B | TRY 199.8B | TRY 1,459.37 | 1.51% down | 169% up | ||
| 60 | ErascaERAS · Health Care | TRY 20B | TRY 239.3B | TRY 681.90 | 2.66% down | 403% up | ||
| 61 | VeradermicsMANE · Health Care | TRY 7.7B | TRY 265.3B | TRY 6,288.39 | 0.76% down | 233% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Total assets is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 50.4362 TRY).
Questions and answers
Which pharmaceutical companies rank first by total assets?
Pfizer (TRY 10.5T), Johnson & Johnson (TRY 10.05T) and Sanofi (TRY 7.1T) are the top three of the 61 pharmaceutical companies ranked by total assets as of 18 Nov 2026, 18:41 UTC.
How many pharmaceutical companies are in this ranking?
61 are ranked by total assets.
What are these pharmaceutical companies worth together?
The 61 pharmaceutical companies ranked by total assets have a combined market value of TRY 256.86T as of 18 Nov 2026, 18:41 UTC.
What does ranking by total assets measure?
Everything the company owns, as its balance sheet stood at the end of the latest fiscal year.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest pharmaceutical companies by total assets”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=total-assets
Underlying data: Yahoo Finance; SEC EDGAR.